These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11685108)

  • 1. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients.
    Ovuworie CA; Fox ER; Chow CM; Pascual M; Shih VE; Picard MH; Tolkoff-Rubin NE
    Transplantation; 2001 Oct; 72(8):1385-8. PubMed ID: 11685108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?
    Mercanoglu F; Oflaz H; Turkmen A; Kocaman O; Bunyak B; Umman S; Yekeler E; Kasikcioglu E; Meric M; Demirel S; Kucuk M; Sever MS
    Transplant Proc; 2004 Jun; 36(5):1361-6. PubMed ID: 15251333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels.
    Mercanoglu F; Turkmen A; Kocaman O; Pinarbasi B; Dursun M; Selcukbiricik F; Sever MS
    Transplant Proc; 2004 Jun; 36(5):1357-60. PubMed ID: 15251332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hemorheology and endothelial dysfunction in renal transplant patients receiving calcineurin inhibitors.
    Akoglu H; Seringec N; Yildirim T; Yilmaz R; Okutucu S; Turkmen E; Evranos B; Kaya EB; Dikmenoglu N; Arici M; Erdem Y; Turgan C
    J Nephrol; 2013; 26(5):931-40. PubMed ID: 23147686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients.
    Oflaz H; Turkmen A; Kazancioglu R; Kayacan SM; Bunyak B; Genchallac H; Erol B; Mercanoglu F; Umman S; Sever MS
    Clin Transplant; 2003 Jun; 17(3):212-6. PubMed ID: 12780670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index.
    Grabczewska Z; Obońska K; Adamowicz A; Kasprzak M; Włodarczyk Z; Kubica J
    Transplant Proc; 2013 May; 45(4):1567-70. PubMed ID: 23726621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients.
    Hausberg M; Kisters K; Kosch M; Rahn KH; Barenbrock M
    Kidney Int; 1999 Mar; 55(3):1104-10. PubMed ID: 10027950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
    Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
    J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy.
    Sata M; Walsh K
    Biochem Biophys Res Commun; 1999 Sep; 263(2):430-2. PubMed ID: 10491310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
    Baid-Agrawal S; Delmonico FL; Tolkoff-Rubin NE; Farrell M; Williams WW; Shih V; Auchincloss H; Cosimi AB; Pascual M
    Transplantation; 2004 Apr; 77(8):1199-202. PubMed ID: 15114085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of erythropoietin on arterial stiffness and endothelial function in renal transplant recipients.
    Bartels V; Hillebrand U; Kosch M; Hausberg M; Kisters K; Di Marco GS; Reiermann S; Pavenstaedt H; Lang D
    Am J Nephrol; 2012; 36(4):355-61. PubMed ID: 23038220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R; Pastor MC; Bayes B; Malumbres S; Homs M; Llopis MA; Bonet J; Romero R
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
    Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
    Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy.
    Sahin G; Akay OM; Uslu S; Bal C; Yalcin AU; Gulbas Z
    Nephrology (Carlton); 2015 Jun; 20(6):392-8. PubMed ID: 25650527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidaemia among renal transplant recipients: cyclosporine versus tacrolimus.
    Fazal MA; Idrees MK; Akhtar SF
    J Pak Med Assoc; 2014 May; 64(5):496-9. PubMed ID: 25272531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
    Zadrazil J; Horak P; Zahalkova J; Strebl P; Horcicka V; Krejci K; Bachleda P; Dedochova J; Valkovsky I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):67-73. PubMed ID: 19365530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects.
    Klein IH; Abrahams A; van Ede T; Hené RJ; Koomans HA; Ligtenberg G
    Transplantation; 2002 Mar; 73(5):732-6. PubMed ID: 11907418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.